These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 6510350)
1. [Production of antibodies by hybridomas in a serum-free culture medium]. Pinchuk GV; Volgin AIu; Chernikov VG Eksp Onkol; 1984; 6(5):74-5. PubMed ID: 6510350 [TBL] [Abstract][Full Text] [Related]
2. Medium-scale production and purification of monoclonal antibodies in protein-free medium. Tarleton RL; Beyer AM Biotechniques; 1991 Nov; 11(5):590-3. PubMed ID: 1804247 [TBL] [Abstract][Full Text] [Related]
3. [Production of monoclonal antibodies in serum-free medium in dialysis tubing]. Witt S; Ziegler B; Blumentritt C; Schlosser M; Ziegler M Allerg Immunol (Leipz); 1991; 37(2):67-74. PubMed ID: 1801593 [TBL] [Abstract][Full Text] [Related]
4. A serum independent medium effective in all aspects of hybridoma technology and immunological applications. Baker P; Knoblock K; Noll L; Wyatt D; Lydersen B Dev Biol Stand; 1985; 60():63-72. PubMed ID: 3876250 [TBL] [Abstract][Full Text] [Related]
5. Efficient methods for production of monoclonal antibodies for forensic applications. Tamaki Y; Kishida T Nihon Hoigaku Zasshi; 1992 Dec; 46(6):424-7. PubMed ID: 1303446 [TBL] [Abstract][Full Text] [Related]
6. Optimization of growth and secretion of human monoclonal antibodies by hybridomas cultured in serum-free media. Lang AB; Schuerch U; Cryz SJ Hybridoma; 1991 Jun; 10(3):401-9. PubMed ID: 1916851 [TBL] [Abstract][Full Text] [Related]
7. [Defined media for hybridoma culture: do they really replace serum and why are they attractive?]. Boschetti E; Pouradier Duteil X; Sene C Ann Pharm Fr; 1991; 49(4):198-208. PubMed ID: 1781602 [TBL] [Abstract][Full Text] [Related]
8. Differences in the glycosylation profile of a monoclonal antibody produced by hybridomas cultured in serum-supplemented, serum-free or chemically defined media. Serrato JA; Hernández V; Estrada-Mondaca S; Palomares LA; Ramírez OT Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):113-24. PubMed ID: 17250495 [TBL] [Abstract][Full Text] [Related]
9. Serum preparation and methods for the large-scale production of IgG monoclonal antibody. Zeng QS; Takeyama H; Kanda S; Irie RF Hum Antibodies Hybridomas; 1994; 5(1-2):75-80. PubMed ID: 7858185 [TBL] [Abstract][Full Text] [Related]
10. A hollow fibre dialysis system for the in vitro production of monoclonal antibodies replacing in vivo production in mice. Schönherr OT; van Gelder PT; van Hees PJ; van Os AM; Roelofs HW Dev Biol Stand; 1987; 66():211-20. PubMed ID: 3582749 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody enhancement in protein-free and serum-supplemented hybridoma culture. Fike RM; Jayme DW; Weiss SA Am Biotechnol Lab; 1991 Jun; 9(5):40, 42. PubMed ID: 1367585 [No Abstract] [Full Text] [Related]
12. Kinetic analysis of hybridoma cells viability under mechanical shear stress with and without serum protection. Legazpi L; Laca A; Díaz M Bioprocess Biosyst Eng; 2009 Oct; 32(6):717-22. PubMed ID: 19153770 [TBL] [Abstract][Full Text] [Related]
13. [Production of monoclonal antibodies]. van Ewijk W Tijdschr Diergeneeskd; 1985 Oct; 110(20):814-7. PubMed ID: 3878010 [TBL] [Abstract][Full Text] [Related]
14. Cross flow diafiltration of serum with basal medium suitable for growth of hybridomas, sterilization and protein reduction. Jungbauer A; Wenisch E; Steindl F; Himmler G; Reiter S; Rüker F; Wagner K; Katinger H Dev Biol Stand; 1987; 66():87-90. PubMed ID: 3582774 [TBL] [Abstract][Full Text] [Related]
15. Use of electric-field-mediated cell fusion to produce hybridomas secreting monoclonal antibodies. Zhao X Methods Mol Biol; 1995; 45():61-7. PubMed ID: 7550693 [No Abstract] [Full Text] [Related]
16. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium. Johnson M; Lanthier S; Massie B; Lefebvre G; Kamen AA Biotechnol Prog; 1996; 12(6):855-64. PubMed ID: 8983210 [TBL] [Abstract][Full Text] [Related]
17. Generation of somatic cell hybrids capable of proliferating and secreting human monoclonal antibody without any growth factor supplements. Hagiwara H; Yuasa H Hum Antibodies Hybridomas; 1993 Jan; 4(1):15-9. PubMed ID: 8431553 [TBL] [Abstract][Full Text] [Related]
18. Early screening for hybrid antibodies. Loevborg U Dev Biol Stand; 1983; 55():173-9. PubMed ID: 6677530 [TBL] [Abstract][Full Text] [Related]
19. Pilot-scale production of murine monoclonal antibodies in agitated, ceramic-matrix or hollow-fiber cell culture systems. Kurkela R; Fraune E; Vihko P Biotechniques; 1993 Oct; 15(4):674-83. PubMed ID: 8251170 [TBL] [Abstract][Full Text] [Related]
20. Antibody production by human X human hybridomas in serum-free medium. Cole SP; Vreeken EH; Roder JC J Immunol Methods; 1985 Apr; 78(2):271-8. PubMed ID: 3989311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]